Mirum Pharmaceuticals, Inc. (MIRM)
102.18
-9.20
(-8.26%)
USD |
NASDAQ |
May 15, 16:00
102.25
+0.06
(+0.06%)
After-Hours: 20:00
Mirum Pharmaceuticals Shareholders Equity (Quarterly) : 242.49M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BridgeBio Pharma, Inc. | -2.278B |
| BioMarin Pharmaceutical, Inc. | 6.212B |
| Insmed, Inc. | 704.85M |
| Ionis Pharmaceuticals, Inc. | 491.41M |
| AnaptysBio, Inc. | 12.75M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 890.92M |
| Total Liabilities (Quarterly) | 648.42M |
| Debt to Equity Ratio | 1.335 |
| Current Ratio | 2.087 |
| Net Debt Paydown Yield | -0.02% |